Chronic Kidney Disease-associated Pruritus
Mc2 Therapeutics Limited is active in pruritus linked to chronic kidney disease, with clinical research centred on symptom relief in adults affected by persistent itching.
- CKD-associated itch
- Topical dermatologic therapy
- Symptom control in renal disease
The sponsor’s research interest in this area focuses on treatment options for a burdensome cutaneous symptom in the setting of renal impairment.
Vulvar Lichen Sclerosus
The sponsor also studies vulvar lichen sclerosus, a chronic inflammatory condition affecting the vulvar tissue and associated with discomfort and skin changes.
- Inflammatory vulvar disorders
- Chronic dermatologic conditions
- Female genital skin disease
Clinical activity in this field reflects interest in therapies for long-term management of vulvar dermatoses.
Topical Dermatology
Across its trial portfolio, Mc2 Therapeutics Limited is focused on topical treatment for localized symptoms and skin inflammation.
- Topical cream formulations
- Local anti-inflammatory treatment
- Dermatologic symptom management
Its research activity is concentrated on skin-directed interventions for conditions requiring sustained external therapy.
Inflammatory and Pruritic Disorders
The sponsor’s clinical interests extend to disorders defined by inflammation, itch, and chronic irritation, particularly where symptoms affect quality of life.
- Chronic itch syndromes
- Inflammatory skin disease
- Symptom-focused dermatology
This includes therapeutic areas where control of pruritic symptoms is a central clinical need.
